Top sustainability award for Hinxton Hall Conference Centre

The Hinxton Hall Conference Centre, based at the Wellcome Genome Campus, has achieved a Silver Award from Green Tourism, the largest and most established sustainable certification programme in the world.

Ubiquigent appoints Dr Rishi Shah as Head of Chemistry

Appointment brings extensive heterobifunctional and chemical biology expertise in house to drive forward Ubiquigent’s internal DUBTAC drug discovery and DUB-focused partnerships

Danaher to acquire Abcam - valuing the Cambridge company at $5.7bn

Cambridge, UK / Waltham, MA - Abcam plc, a global leader in the supply of life science research tools, announces that it has entered into a definitive agreement pursuant to which Danaher Corporation will acquire all of the outstanding shares of Abcam for $24.00 per share in cash.

Unique new technology enhances mobile functionality in healthcare

Cambridge based health tech company, electronRx, has developed an API solution for mobile phones that will be a step change in  healthcare.

Celebrating our Centres - Exeter

This week we hear from our colleagues in the southwest about post-pandemic recruitment milestones, engaging with local community at agricultural shows, their Cystic Fibrosis and Monogenic Beta Cell Diabetes team, and collaborative work to increase the diversity of public involvement groups.

An international comparative analysis and roadmap to sustainable biosimilar markets

This study was originally published in Frontiers in Pharmacology.

AstraZeneca demonstrates scientific leadership with compelling new data at ESC Congress 2023 on the interconnections across chronic diseases

Wealth of heart failure data supports medical guideline updates and underscores commitment to improving patient outcomes.

Lightcast Discovery secures $49 million in Series B financing to commercialize its single-cell platform for functional analysis

Cambridge, UK - Lightcast Discovery Ltd., a life science tools company developing a novel single-cell functional analysis platform, announces the completion of a £38M (c. $49 million) Series B funding round, led by M Ventures. Current investors joining the round include ARCH Venture Partners, Illumina Ventures, OMX Ventures, +ND Capital and Longwall Ventures. The company also announced the…

Cleopatra Pal joins Salus Wellness Clinics

Salus Wellness Clinics writes...we are very pleased to announce that Cleopatra Pal has joined Salus Wellness this month.

Multiple organ functions of the yolk sac revealed by early human development map

The role of the human yolk sac in supporting early embryonic development and the first wave of the prenatal immune system has been mapped in a study published today (17 August) in Science. 

Celebrating our Centres - Southampton

Our series continues this week with an update from our colleagues in Wessex. The team share some exciting updates including increased BRC funding to expand research themes, their approach to working with researchers and clinicians across the region, and public involvement initiatives coming up.

5 revolutionary women’s health innovations

Over recent years, advancements in medical technology have had a profound impact on healthcare, from improving diagnostics, to enhancing treatment options.

Arecor to collaborate with top 10 global pharmaceutical company

Arecor expands its global partnerships through collaboration to develop an enhanced antibody formulation

Ready to control nitrites?

The ever-changing regulatory environment around nitrosamine contamination in pharmaceutical products means manufacturers face the complex task of controlling nitrosamine levels within their product lines. One of the most effective ways of managing nitrosamine formation is to control the levels of nitrites within the product. Current technologies and methods have struggle to successfully monitor…

New film highlights the importance of kidney research

Patients and staff from Addenbrooke’s are helping a national research charity raise awareness of kidney disease with a powerful new video.

Breathing space: asthma & the NHS

Asthma accounts for 5,000 NHS Emergency Department visits every month, with a dramatic 149% increase in admission for children, costing the NHS more than £3bn in 2022. 

Christmas Party Nights in Cambridge

The festive season is a time for making memories with family, friends and colleagues.

At Hilton Cambridge City Centre, we pride ourselves on knowing how to throw a great party, so let us take away the stress of the holiday season for you.

£13 million for 22 AI for health research projects

Projects aim to transform health using artificial intelligence (AI) to assist and refine diagnostics and procedures.

NIHR BioResource - Celebrating our Centres - Birmingham

The NIHR BioResource Centre Birmingham team have been busy on the ground engaging with local communities at events, talking about the NAFLD BioResource and patient participation on local radio, and getting professional videos made to promote diversity, participation and the value of research.

Major milestones reached for new East of England cancer hospital

Cambridge Cancer Research Hospital (CCRH) has had the second stage of its business case, its Outline Business Case, approved by NHS England, the Department of Health and Social Care and HM Treasury.

Astex expands drug discovery collaboration with MSD

Cambridge, UK - Astex Pharmaceuticals (UK), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announces an exclusive worldwide research collaboration and license agreement with MSD (Merck & Co., Inc., Rahway, N.J., USA). The goal of the collaboration is to identify small molecule…

Medicilon delivers Green Chemistry Solutions for drug development

Environmental pollution and energy waste causes the destruction of ecosystems, extinction of species and global warming, leading to serious and long-lasting global challenges.  To mitigate these challenges, green chemistry approaches are being developed and introduced into chemical and pharmaceutical industries to deliver improved environmental sustainability into drug development and…

Living with SANDO – a long road to diagnosis

42-year-old Mark shares his story living with Sensory Ataxic Neuropathy, Dysarthria, and Ophthalmoparesis (SANDO) disease, a rare mitochondrial condition that affects the brain, muscles, nerves and eyes. He discusses everything from the long road to diagnosis, his brother developing symptoms during adulthood, how it impacts him in daily life, and why he chooses to participate in health research.

Wellcome Sanger Institute highlight skin cancer-related mutations higher in the UK than Singapore

A new study has shown how, on average, people in the UK have facial skin that is far more DNA damaged from the sun than people in Singapore, explaining the far higher risk of developing the most common skin cancers in the UK.

Retina cell breakthrough could help treat blindness

Scientists harness nanotechnology to help tackle a common cause of sight loss.